首页 › 基金 › Invenomic Capital Management LP › EGO

Invenomic Capital Management LP 对 EGO 的持仓历史

ELDORADO GOLD CORP NEW · 材料

Invenomic Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 EGO(ELDORADO GOLD CORP NEW)750,722 股,市值约 US$28.9M,约占其申报组合的 1.43%,在其申报持仓中市值排名第 27 位。 Invenomic Capital Management LP 最近 13 个申报季度中有 13 个季度披露了 EGO 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)750.72K 股
申报持仓市值$28.90M
组合权重1.43%
首次申报Q3 2023
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Invenomic Capital Management LP 对 EGO 的持仓演变

Invenomic Capital Management LP 于 Q3 2023 首次披露 EGO 持仓:2,289,734 股(约 US$20.4M)。 该持仓在 Q3 2025 达到峰值 1,879,102 股,市值约 US$54.3M。 在 13 次申报中,Invenomic Capital Management LP 2 次增持、10 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 750,722 股、市值约 US$28.9M,环比减持 -407,097 股。。 持仓曾出现大幅变动:Q4 2023 减持约 41% (随后一个季度股价上涨 8%)、Q1 2025 增持约 127% (随后一个季度股价上涨 21%)、Q3 2026 减持约 35% (随后一个季度股价下跌 22%)。

逐季持仓明细

季度股数金额变化
Q3 2023 2.29M $20.40M 新进
Q4 2023 1.36M $17.60M 减持
Q1 2024 1.74M $24.45M 增持
Q2 2024 1.64M $24.32M 减持
Q3 2024 1.15M $20.00M 减持
Q4 2024 995.85K $14.81M 减持
Q1 2025 2.26M $38.05M 增持
Q2 2025 2.03M $41.33M 减持
Q3 2025 1.88M $54.29M 减持
Q4 2025 1.50M $53.75M 减持
Q1 2026 1.43M $49.22M 减持
Q2 2026 1.16M $36.00M 减持
Q3 2026 750.72K $28.90M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 EGO 与 13F 数据

EGO(ELDORADO GOLD CORP NEW)属于材料行业。我们追踪的基金中还有 45 只申报持有 EGO,申报仓位最大的包括:L1 Capital Pty Ltd (US$555.5M), FAIRFAX FINANCIAL HOLDINGS LTD/ CAN (US$526.7M), VAN ECK ASSOCIATES CORP (US$488.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 EGO 的基金

查看 EGO 的全部基金持有人 →

常见问题

How long has Invenomic Capital Management LP held EGO?

Invenomic Capital Management LP has disclosed EGO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Invenomic Capital Management LP's current position in EGO?

As of Q3 2026, Invenomic Capital Management LP holds 750.72K shares of EGO (ELDORADO GOLD CORP NEW), valued at $28.90M, representing 1.43% of its reported portfolio and ranking #27.

Has Invenomic Capital Management LP been buying or selling EGO?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP reduced its position in EGO. The position peaked in Q3 2025 at 1.88M shares.

Which other funds hold EGO?

Other major institutional holders of EGO include L1 Capital Pty Ltd, FAIRFAX FINANCIAL HOLDINGS LTD/ CAN, VAN ECK ASSOCIATES CORP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.